Literature DB >> 22090099

Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques.

Nichole R Klatt1, Lauren A Canary, Thomas H Vanderford, Carol L Vinton, Jessica C Engram, Richard M Dunham, Heather E Cronise, Joanna M Swerczek, Bernard A P Lafont, Louis J Picker, Guido Silvestri, Jason M Brenchley.   

Abstract

Pigtail macaques (PTM) are an excellent model for HIV research; however, the dynamics of simian immunodeficiency virus (SIV) SIVmac239 infection in PTM have not been fully evaluated. We studied nine PTM prior to infection, during acute and chronic SIVmac239 infections, until progression to AIDS. We found PTM manifest clinical AIDS more rapidly than rhesus macaques (RM), as AIDS-defining events occurred at an average of 42.17 weeks after infection in PTM compared to 69.56 weeks in RM (P = 0.0018). However, increased SIV progression was not associated with increased viremia, as both peak and set-point plasma viremias were similar between PTM and RM (P = 0.7953 and P = 0.1006, respectively). Moreover, this increased disease progression was not associated with rapid CD4(+) T cell depletion, as CD4(+) T cell decline resembled other SIV/human immunodeficiency virus (HIV) models. Since immune activation is the best predictor of disease progression during HIV infection, we analyzed immune activation by turnover of T cells by BrdU decay and Ki67 expression. We found increased levels of turnover prior to SIV infection of PTM compared to that observed with RM, which may contribute to their increased disease progression rate. These data evaluate the kinetics of SIVmac239-induced disease progression and highlight PTM as a model for HIV infection and the importance of immune activation in SIV disease progression.

Entities:  

Mesh:

Year:  2011        PMID: 22090099      PMCID: PMC3255820          DOI: 10.1128/JVI.06033-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

Review 1.  SIV infection of macaques as a model for AIDS pathogenesis.

Authors:  P R Johnson; V M Hirsch
Journal:  Int Rev Immunol       Date:  1992       Impact factor: 5.311

Review 2.  The simian immunodeficiency viruses.

Authors:  R C Desrosiers
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 3.  Animal models for AIDS.

Authors:  N L Letvin
Journal:  Immunol Today       Date:  1990-09

4.  Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.

Authors:  Y M Naidu; H W Kestler; Y Li; C V Butler; D P Silva; D K Schmidt; C D Troup; P K Sehgal; P Sonigo; M D Daniel
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  Identification of novel MHC class I sequences in pig-tailed macaques by amplicon pyrosequencing and full-length cDNA cloning and sequencing.

Authors:  Claire E O'Leary; Roger W Wiseman; Julie A Karl; Benjamin N Bimber; Simon M Lank; Jennifer J Tuscher; David H O'Connor
Journal:  Immunogenetics       Date:  2009-09-24       Impact factor: 2.846

6.  Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection.

Authors:  N R Klatt; L D Harris; C L Vinton; H Sung; J A Briant; B Tabb; D Morcock; J W McGinty; J D Lifson; B A Lafont; M A Martin; A D Levine; J D Estes; J M Brenchley
Journal:  Mucosal Immunol       Date:  2010-03-31       Impact factor: 7.313

7.  T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.

Authors:  Jason M Brenchley; Brenna J Hill; David R Ambrozak; David A Price; Francisco J Guenaga; Joseph P Casazza; Janaki Kuruppu; Javaidia Yazdani; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Molecular clones of SIVsm and SIVagm: experimental infection of macaques and African green monkeys.

Authors:  P R Johnson; S Goldstein; W T London; A Fomsgaard; V M Hirsch
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

9.  Thrombocytopenia is strongly associated with simian AIDS in pigtail macaques.

Authors:  Sheilajen Alcantara; Jeanette Reece; Thakshila Amarasena; Robert De Rose; Joe Manitta; Janiki Amin; Stephen J Kent
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-01       Impact factor: 3.731

10.  Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.

Authors:  Jörn E Schmitz; Roland C Zahn; Charles R Brown; Melisa D Rett; Ming Li; Haili Tang; Sarah Pryputniewicz; Russell A Byrum; Amitinder Kaur; David C Montefiori; Jonathan S Allan; Simoy Goldstein; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more
  38 in total

Review 1.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

2.  Multicenter Safety and Immunogenicity Trial of an Attenuated Measles Vaccine for NHP.

Authors:  Joann L Yee; Michael B McChesney; Kari L Christe
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

3.  Identification of the peptide-binding motif recognized by the pigtail macaque class I MHC molecule Mane-A1*082:01 (Mane A*0301).

Authors:  Carrie Moore; John Sidney; A Michelle English; Amanda Wriston; Donald F Hunt; Jeffrey Shabanowitz; Scott Southwood; Kate Bradley; Bernard A P Lafont; Bianca R Mothé; Alessandro Sette
Journal:  Immunogenetics       Date:  2012-01-26       Impact factor: 2.846

4.  Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection.

Authors:  Christopher W Peterson; Patrick Younan; Patricia S Polacino; Nicholas J Maurice; Hannah W Miller; Martin Prlic; Keith R Jerome; Ann E Woolfrey; Shiu-Lok Hu; Hans-Peter Kiem
Journal:  J Med Primatol       Date:  2013-10       Impact factor: 0.667

Review 5.  Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.

Authors:  LiGuo Zhang; Eric Meissner; JianZhu Chen; LiShan Su
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

6.  Probiotic/prebiotic supplementation of antiretrovirals improves gastrointestinal immunity in SIV-infected macaques.

Authors:  Nichole R Klatt; Lauren A Canary; Xiaoyong Sun; Carol L Vinton; Nicholas T Funderburg; David R Morcock; Mariam Quiñones; Clayton B Deming; Molly Perkins; Daria J Hazuda; Michael D Miller; Michael M Lederman; Julie A Segre; Jeffrey D Lifson; Elias K Haddad; Jacob D Estes; Jason M Brenchley
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

Review 7.  Comparison of the vaginal environment of Macaca mulatta and Macaca nemestrina throughout the menstrual cycle.

Authors:  Sarah V Hadzic; Xiaolei Wang; Jason Dufour; Lara Doyle; Preston A Marx; Andrew A Lackner; Daniel B Paulsen; Ronald S Veazey
Journal:  Am J Reprod Immunol       Date:  2014-02-13       Impact factor: 3.886

Review 8.  Nonhuman primate models of human viral infections.

Authors:  Jacob D Estes; Scott W Wong; Jason M Brenchley
Journal:  Nat Rev Immunol       Date:  2018-06       Impact factor: 53.106

9.  Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression.

Authors:  Matthew W Breed; Andrea P O Jordan; Pyone P Aye; Cornelis F Lichtveld; Cecily C Midkiff; Faith R Schiro; Beth S Haggarty; Chie Sugimoto; Xavier Alvarez; Netanya G Sandler; Daniel C Douek; Marcelo J Kuroda; Bapi Pahar; Michael Piatak; Jeffrey D Lifson; Brandon F Keele; James A Hoxie; Andrew A Lackner
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 10.  Animal models for HIV/AIDS research.

Authors:  Theodora Hatziioannou; David T Evans
Journal:  Nat Rev Microbiol       Date:  2012-12       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.